Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Investors use market indices for benchmarking, asset allocation, and risk management, enabling efficient, cost-effective exposure to markets.
27,738 articlesDanish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
U.S. inflation climbs above 4% for the first time since 2023, renewing pressure on the Fed and prompting traders to r...
A market dip in the chip sector created a rare buying opportunity. This guide features three thoughtful picks to own ...
Adobe has fallen sharply in 2026, prompting a rotation debate toward Alphabet as AI momentum and big-cap investments ...
Altria sits around $73 with a near-6% yield, yet a from 52-week low: glaring risk and consumer softness raise questio...
A disciplined income plan built around a $750,000 portfolio can generate reliable cash flow, potentially exceeding to...
In the latest quarter, many hedge funds bought stakes in RidgePoint Heavy Equipment, a niche rental firm. The move si...
As AI accelerates, Microsoft reports robust AI-driven revenue while stock faces capex-related volatility. This piece ...
Leidos stock plummeted this week as analysts reevaluate targets and government-contract exposure. This guide breaks d...
FedEx reports earnings Tuesday, and traders want a clear take on demand, costs, and guidance. This guide breaks down ...
Cardano’s founder positions AI agents as essential infra for Midnight City, while ADA hovers near $0.16 as traders we...
Bitcoin trading near $60K faces renewed downside pressure after failing to sustain a weekend bounce. Bulls must defen...